Voltar
Artigo Revisado por pares
BIBTEX RIS

Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

2008; Springer Science+Business Media; Volume: 27; Issue: 2 Linguagem: Inglês

10.1007/s10637-008-9166-8

ISSN

1573-0646

Autores

Georgia Schilling, M. Bruweleit, Nadia Harbeck, Christoph Thomssen, Karl‐Friedrich Becker, Ramona Hoffmann, C. Villena, M. Schütte, Dieter K. Hossfeld, Carsten Bokemeyer, Maike de Wit,

Tópico(s)

Peptidase Inhibition and Analysis

Referência(s)